Funding · Commerce & Consumer Brands

iD Fresh gets ₹1,300 Cr investment from Apax Partners

By Startup Enthusiast · 5 January 2026

What they do

ID Fresh makes ready-to-cook foods like idli batter, dosa batter, and frozen flatbreads

Apax Partners invests ₹1,300 Cr ($144 Mn) for a 25% stake; existing sellers include Premji Invest and TPG NewQuest

The company turned profitable in FY24 and plans to become IPO-ready in FY26 with a pre-IPO secondary sale

iD Fresh announced a strategic investment from Apax Partners for a significant minority stake of ₹1,300 Cr.
Apax Partners will invest ₹1,300 Cr ($144 Mn) for a 25% stake in the company.
The deal values iD Fresh at ₹4,500 Cr post-investment.
Existing shareholders Premji Invest and TPG NewQuest are selling their shares in this transaction.
The funds will be used to enhance the product catalogue and expand across new markets in India and abroad.
iD Fresh is gearing up to become IPO-ready in FY26 along with a pre-IPO secondary sale worth about ₹1,200 Cr.
The company targets operating revenue of ₹1,100-1,200 Cr by FY27.

iD Fresh turned profitable in FY24 with a net profit of ₹1.84 Cr, compared to a loss of ₹23.3 Cr in FY23.
Its operating revenue surged past ₹600 Cr in FY25, with total revenue of ₹688.22 Cr, up 22.3% from the previous fiscal.
Apax Partners has spent close to $3.5 Bn in India since 2007, with portfolio companies including Fractal Analytics and Apollo Hospitals.

iD Fresh is a ready-to-cook food retailer, best known for its flagship idli and dosa batters.
It also sells instant breakfast mixes, frozen Indian flatbreads, pancake and coffee mixes, and dairy products like curd and paneer.
The company has expanded its product categories to include a wide range of convenient food items.
iD Fresh operates in India and international markets, with a focus on distribution and retail presence.
The company turned profitable in FY24 and reported a profit before tax of ₹26.7 Cr in FY25.

Enhance product catalogue and expand across new markets in India and abroad.
Deepen penetration across domestic and international markets and distribution channels.
Innovate new product lines to drive growth.
Become IPO-ready in FY26 with a pre-IPO secondary sale worth about ₹1,200 Cr.
Target operating revenue of ₹1,100-1,200 Cr by FY27.

Apax Partners (lead) — London-based private equity firm with a portfolio including Fractal Analytics, IBS Software, and Apollo Hospitals.
Premji Invest (seller) — Existing shareholder selling its stake in this transaction.
TPG NewQuest (seller) — Existing shareholder selling its stake in this transaction.